Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

BPH Global launches pilot study for adult milk powder infused with raw birds’ nest and seaweed in China

  • In News
  • May 14, 2024
  • Alfred Chan
BPH Global launches pilot study for adult milk powder infused with raw birds’ nest and seaweed in China

While milk powder has long been classified in the realm of infant consumption, its value in fact extends to the opposite end of the age spectrum, a trend that plant-based biotech company BPH Global (ASX: BP8) is aiming to capitalise on through a new pilot study in China. 

The study for adult milk formula will take place in China, in collaboration with Nutura Organic, an Australian-based firm renowned for its nutrition products derived from Australian sourced milk.

The term sheet, a legally binding agreement between BPH Global and Nutura, outlines the acquisition of Nutura’s flagship product, the “Adult 60+ Milk Formula,” for the pilot study. This product, compliant with Chinese standards, marks Nutura’s entry into the vast Chinese market.

Driven by a commitment to explore opportunities in food products that align with Traditional Chinese Medicine (TCM) principles, BPH Global aims to gauge the market potential for Nutura’s Adult Milk Formula amongst consumers in China. 

The study plans to infuse the milk formula with TCM-based ingredients such as sialic acid, nutraceuticals extracted from raw birds’ nest, and seaweed. 

The pilot program is strategically designed to assess various aspects, including logistics, cost-effectiveness, and consumer demand. BPH Global will evaluate the feasibility and commercial viability of importing the Adult Milk Formula, incorporating TCM-based elements, and distributing the product through retail channels in China.

Key terms of the term sheet reveal an initial purchase of 3,500 units of Adult Milk Formula at an aggregate price of approximately $35,000. Nutura has offered a rebate to support marketing and promotional activities associated with the pilot study. Additionally, Nutura is tasked with ensuring that the Adult Milk Formula complies with Chinese standards.

The term sheet remains valid until the completion of obligations regarding the purchase order, indicating a commitment to ongoing collaboration between Nutura and BPH Global. Both parties are poised to explore future opportunities for supplying Nutura’s products in the Chinese market, focusing on the Adult Milk Formula infused with TCM-based ingredients.

The launch of this pilot study underscores the growing demand for specialised nutrition products among Chinese consumers. With an aging population and increasing health awareness, there is a burgeoning market for functional foods that offer targeted health benefits. 

Furthermore, the integration of TCM-based ingredients resonates with Chinese consumers who value holistic approaches to health and wellness.

As the pilot study unfolds, BPH Global and Nutura Organic Ltd anticipate valuable insights that will inform future strategies for penetrating the Chinese market. With a focus on quality, compliance, and consumer satisfaction, this collaboration signals a significant milestone in the global expansion efforts of both companies.

 

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • adult milk formula
  • asx bp8
  • bph global
  • nutura
  • tcm
  • traditional chinese medicine
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    April 16, 2025, 6:45 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/adult-nutritional-milk-powder

    Reply
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.